Increasing Engagement in PTSD Treatment Through Patient Education and Patient Choice

Sponsor
Michael E. DeBakey VA Medical Center (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT01446146
Collaborator
South Central VA Mental Illness Research, Education & Clinical Center (U.S. Fed)
27
1
2
15
1.8

Study Details

Study Description

Brief Summary

The purpose of this program is to compare two different methods of matching a Veteran to a PTSD treatment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Informed decision making
  • Behavioral: Placebo session
N/A

Detailed Description

Posttraumatic Stress Disorder (PTSD) is a serious disorder that affects many Veterans who have had a traumatic experience. The VA offers several different types of treatment for PTSD. We are researching different ways to match a Veteran to a type of treatment. Participants in this study will will be randomly assigned to either a 40-minute session in which they will learn about PTSD treatments and select a preferred treatment or to a 40-minute assessment interview. Those participants assigned to the assessment interview will have the opportunity to work with their Trauma Recovery Program provider to determine a plan for their PTSD treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
27 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Study Start Date :
Oct 1, 2011
Actual Primary Completion Date :
Jan 1, 2013
Actual Study Completion Date :
Jan 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: IDM intervention

Will receive a 40 minute intervention session with a clinician, learning about PTSD treatment options and choosing a preferred treatment.

Behavioral: Informed decision making
40 minute session with a clinician. Participants will learn about the available PTSD treatment options and will be given a decision aid with more information.

Placebo Comparator: Treatment as usual plus placebo session

Will work with provider to select a treatment plan and will receive a 40 minute session without IDM intervention.

Behavioral: Placebo session
Participant will complete clinician-administered measures in a 40-minute session.

Outcome Measures

Primary Outcome Measures

  1. Treatment participation [4 months]

    Trauma Recovery Program service utilization as assessed by chart review.

Secondary Outcome Measures

  1. Treatment satisfaction [4 months]

    Assessed via self-report measures (Client Satisfaction Questionnaire, Credibility/Expectancy Questionnaire) and semi-structured interview

  2. Change in PTSD severity [Baseline and 4 months]

    Assessed by the PCL-M at baseline and 4 month follow-up

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of combat-related PTSD

  • Newly enrolled in Trauma Recovery Program (TRP) at the Michael E. DeBakey VA medical center

  • TRP provider approval

Exclusion Criteria:
  • Previous participation in TRP treatment for PTSD

Contacts and Locations

Locations

Site City State Country Postal Code
1 Michael E. DeBakey VA Medical Center Houston Texas United States 77030

Sponsors and Collaborators

  • Michael E. DeBakey VA Medical Center
  • South Central VA Mental Illness Research, Education & Clinical Center

Investigators

  • Principal Investigator: Juliette M Mott, PhD, MDVAMC, BCM, SC MIRECC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Juliette Mott, Principal Investigator, Michael E. DeBakey VA Medical Center
ClinicalTrials.gov Identifier:
NCT01446146
Other Study ID Numbers:
  • H-28111
First Posted:
Oct 5, 2011
Last Update Posted:
Jul 24, 2013
Last Verified:
Jul 1, 2013
Keywords provided by Juliette Mott, Principal Investigator, Michael E. DeBakey VA Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 24, 2013